InnoCare Pharma Doses First Patient in Global Phase II Trial of Soficitinib for Prurigo Nodularis

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced tha...

December 01, 2025 | Monday | News
Eisai and Biogen Submit Subcutaneous Lecanemab (LEQEMBI®) Application to Japan’s PMDA

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachuse...

December 01, 2025 | Monday | News
SK Biopharmaceuticals Deepens Radiopharma Strategy With Exclusive License to WT-7695 From WARF

  New addition strengthens SK Biopharmaceuticals' radiopharmaceutical therapy portfolio and reinforces its R&D capabilities through global partne...

November 28, 2025 | Friday | News
Sanyou Bio and FatiAbGen Forge Strategic Alliance to Accelerate Global Antibody Discovery

  Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio") and South Korea's FatiAbGen Co., Ltd. today jointly announced the signing of a compre...

November 28, 2025 | Friday | News
Celltrion Secures EU Green Light for Omlyclo™ 300 mg PFS, Enhancing Biosimilar Options for Allergic Diseases

  Omlyclo™ (omalizumab) is the first and only omalizumab biosimilar approved in Europe Omlyclo™ 300 mg/2ml prefilled syringe (PFS) p...

November 28, 2025 | Friday | News
Galux Demonstrates Precision AI Platform That Delivers Drug-Grade Antibodies in Weeks

-Galux, a South Korean biotech pioneering AI-driven protein therapeutics design, announced new experimental findings demonstrating that its AI protein de...

November 27, 2025 | Thursday | News
Nxera Realigns Strategic Priorities to Advance Next-Generation GPCR Medicines and AI-Enabled Discovery

Nxera Pharma Co., Ltd. announced a focused restructuring designed to concentrate investment and resources on efficient platforms, programs and products w...

November 18, 2025 | Tuesday | News
Teijin and BioVaram Form Strategic Alliance to Advance Regenerative Medicine and Implantable Devices Between Japan and India

Teijin Limited and BioVaram, the brand name of the UR Advanced Therapeutics Pvt Ltd. (URAT), announced that they have signed a business alliance agreement ...

November 14, 2025 | Friday | News
Angelini Ventures Expands to Asia with Singapore Hub to Power Biotech and Healthtech Innovation

Launched its first Asia office to support biotech and healthtech innovation and collaboration within the region The Asia office will house the Angelin...

November 14, 2025 | Friday | News
China’s NMPA Clears Mabwell’s 9MW3811 for Phase II Study in Pathological Scarring

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that its novel anti‑IL‑11 monoclonal antibo...

November 12, 2025 | Wednesday | News
LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in Primary Sclerosing Cholangitis

 LISCure Biosciences ("LISCure"), a clinical-stage biopharmaceutical company, announced the initiation of patient dosing in a global Phase 2 cl...

November 11, 2025 | Tuesday | News
Clearmind Medicine Files Patent in South Korea for MEAI in Depression Treatment

Patent expands MEAI’s global intellectual property protection as Clearmind advances clinical development and commercialization plans Clearmind Med...

November 06, 2025 | Thursday | News
CARsgen Reports Promising Early Clinical Data for Allogeneic CAR-T Candidates CT0596 and CT1190B in Multiple Myeloma and Lymphoma

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces clinical data for...

November 04, 2025 | Tuesday | Reports
Sanyou Biopharmaceuticals and Shanghai ZJ Bio-Tech Forge Strategic Partnership to Automate Innovative Biologics Development

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Shanghai ZJ Bio-Tech technology Co., Ltd. (hereinafter refer...

November 04, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close